Yahoo Finance Curious about International Flavors (IFF) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Wall Street analysts forecast that International Flavors (IFF) will report quarterly earnings of $0.84 per share in its upcoming release, pointing to a year-over-year decline of 3.5%. It is anticipated that revenues will amount to $2.81 billion, exhibiting a decline of 7.3% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 1.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some International Flavors metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Net Sales- Nourish' to come in at $1.46 billion. The estimate points to a change of -11.9% from the year-ago quarter.
Analysts predict that the 'Net sales- Scent' will reach $605.50 million. The estimate indicates a change of -0.4% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Pharma Solutions' will reach $233.65 million. The estimate indicates a change of -7.7% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Health & Biosciences' of $521.86 million. The estimate suggests a change of +1.7% year over year.
Analysts forecast 'Adjusted Operating EBITDA- Nourish' to reach $193.36 million. The estimate compares to the year-ago value of $208 million.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Pharma Solutions' should arrive at $45.89 million. The estimate is in contrast to the year-ago figure of $59 million.
Analysts' assessment points toward 'Adjusted Operating EBITDA- Scent' reaching $109.64 million. The estimate compares to the year-ago value of $105 million.
The average prediction of analysts places 'Adjusted Operating EBITDA- Health & Biosciences' at $144.05 million. The estimate compares to the year-ago value of $131 million.
View all Key Company Metrics for International Flavors here>>>
Shares of International Flavors have experienced a change of +0.5% in the past month compared to the -4.1% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), IFF is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Flavors & Fragrances Inc. (IFF) : Free Stock Analysis Report
